Gamma delta T cells in cancer therapy
Author Information
Author(s): Luo Xinyu, Lv Yufan, Yang Jinsai, Long Rou, Qiu Jieya, Deng Yuqi, Tang Guiyang, Zhang Chaohui, Li Jiale, Zuo Jianhong
Primary Institution: University of South China
Hypothesis
γδ T cells can overcome limitations of traditional immunotherapies in cancer treatment.
Conclusion
γδ T cells show promise in cancer therapy due to their unique mechanisms of tumor recognition and immunomodulation.
Supporting Evidence
- γδ T cells can recognize various antigens and perform multiple roles, including antitumor activities.
- Recent research has started to reveal the various roles of γδ T cells in the tumor microenvironment.
- γδ T cells exhibit moderate cytotoxicity against tumor cells without phosphoantigens.
Takeaway
Gamma delta T cells are special immune cells that can help fight cancer by recognizing tumors in a different way than regular T cells.
Methodology
This review discusses the biological properties of γδ T cells, their role in the tumor microenvironment, and recent clinical advances in γδ T cell-based immunotherapies.
Limitations
The biological functions and clinical applications of γδ T cells are still relatively understudied.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website